Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Poster Presentations: Behavioral Medicine, Clinical Nutrition, Education, and Exercise

719-P: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Glucose-Lowering Effect of Green Jackfruit Flour in Type 2 Diabetes Mellitus Patients

  1. JAMES JOSEPH,
  2. A. GOPAL RAO and
  3. SUNIL NAYAK
  1. Ernakulam, India, Srikakulam, India
Diabetes 2020 Jun; 69(Supplement 1): -. https://doi.org/10.2337/db20-719-P
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Objective: We tested the effects of 30g Jackfruit365™ Green Jackfruit flour in participants with type 2 diabetes (T2DM) as an integral part of daily meal by observing change of glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG) and postprandial glucose (PPG) in blood from baseline.

Research Design and Methods: A randomized double blind design was used in 40 participants with T2DM. Glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), postprandial glucose (PPG) were determined at day 0 (pre-dose) and 84 day (12 weeks). Paired t test was used for statistical analysis of changes within the group and independent t test was used for statistical analysis of changes between the groups.

Results: There were 40 participants with type 2 diabetes mellitus having mean age of 46.20±9.12 years (24 males and 16 females). One participant was lost to follow up in placebo group and total 39 participants with type 2 diabetes mellitus completed the study. In participants taking Green Jackfruit Flour meal, mean HbA1c at baseline was 7.23 ± 0.47 % and at end of study (12 weeks) mean HbA1c was 6.98 ± 0.48%. In participants taking placebo meal, mean HbA1c at baseline was 7.26 ± 0.45 % and at end of study (12 weeks) mean HbA1c was 7.28 ± 0.49%. A significant decrease in HbA1c was observed in participants taking Green Jackfruit flour meal (HbA1c mean difference of 0.25 in Green Jackfruit flour meal vs. -0.02 placebo meal; p =0.006) from baseline to end of the study. Fasting and Postprandial plasma glucose levels also showed similar improvements in participants taking Green Jackfruit flour meal.

Conclusions: Our results indicate decrease in Glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), postprandial glucose (PPG) following consumption of Jackfruit365™ Green Jackfruit flour meal, suggesting a therapeutic potential of Green Jackfruit flour meal in improving glycemic control in T2DM.

Disclosure J. Joseph: Board Member; Self; Diet Fibre 365 Food Products Pvt Ltd. Stock/Shareholder; Self; God’s Own Food Solutions Pvt Ltd. Other Relationship; Self; God’s Own Food Solutions Pvt Ltd. A. Rao: None. S. Nayak: None.

Funding Diet Fibre 365 Food Products Private Limited

  • © 2020 by the American Diabetes Association
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 69 (Supplement 1)

In this Issue

June 2020, 69(Supplement 1)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
719-P: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Glucose-Lowering Effect of Green Jackfruit Flour in Type 2 Diabetes Mellitus Patients
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
719-P: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Glucose-Lowering Effect of Green Jackfruit Flour in Type 2 Diabetes Mellitus Patients
JAMES JOSEPH, A. GOPAL RAO, SUNIL NAYAK
Diabetes Jun 2020, 69 (Supplement 1) 719-P; DOI: 10.2337/db20-719-P

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

719-P: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Glucose-Lowering Effect of Green Jackfruit Flour in Type 2 Diabetes Mellitus Patients
JAMES JOSEPH, A. GOPAL RAO, SUNIL NAYAK
Diabetes Jun 2020, 69 (Supplement 1) 719-P; DOI: 10.2337/db20-719-P
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

Poster Presentations: Behavioral Medicine, Clinical Nutrition, Education, and Exercise

  • 695-P: Grand-Maternal Exercise Improves Glucose Tolerance in Second Generation Offspring
  • 704-P: Influence of Acute Stress on Heart Rate and Glycemia during Exercise
  • 662-P: Oral Health: Neglected Diabetes Intervention
Show more Poster Presentations: Behavioral Medicine, Clinical Nutrition, Education, and Exercise

P: Nutrition—Clinical

  • 695-P: Grand-Maternal Exercise Improves Glucose Tolerance in Second Generation Offspring
  • 704-P: Influence of Acute Stress on Heart Rate and Glycemia during Exercise
  • 662-P: Oral Health: Neglected Diabetes Intervention
Show more P: Nutrition—Clinical

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.